1. Home
  2. HROW vs MDAIW Comparison

HROW vs MDAIW Comparison

Compare HROW & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • MDAIW
  • Stock Information
  • Founded
  • HROW 1998
  • MDAIW N/A
  • Country
  • HROW United States
  • MDAIW United States
  • Employees
  • HROW N/A
  • MDAIW 78
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • MDAIW Medical/Dental Instruments
  • Sector
  • HROW Health Care
  • MDAIW Health Care
  • Exchange
  • HROW Nasdaq
  • MDAIW Nasdaq
  • Market Cap
  • HROW N/A
  • MDAIW N/A
  • IPO Year
  • HROW N/A
  • MDAIW N/A
  • Fundamental
  • Price
  • HROW $28.34
  • MDAIW $0.35
  • Analyst Decision
  • HROW Strong Buy
  • MDAIW
  • Analyst Count
  • HROW 5
  • MDAIW 0
  • Target Price
  • HROW $59.00
  • MDAIW N/A
  • AVG Volume (30 Days)
  • HROW 510.1K
  • MDAIW 35.6K
  • Earning Date
  • HROW 05-08-2025
  • MDAIW 02-27-2025
  • Dividend Yield
  • HROW N/A
  • MDAIW N/A
  • EPS Growth
  • HROW N/A
  • MDAIW N/A
  • EPS
  • HROW N/A
  • MDAIW N/A
  • Revenue
  • HROW $212,858,000.00
  • MDAIW $27,264,000.00
  • Revenue This Year
  • HROW $44.37
  • MDAIW N/A
  • Revenue Next Year
  • HROW $37.02
  • MDAIW N/A
  • P/E Ratio
  • HROW N/A
  • MDAIW N/A
  • Revenue Growth
  • HROW 53.49
  • MDAIW 44.52
  • 52 Week Low
  • HROW $16.71
  • MDAIW $0.08
  • 52 Week High
  • HROW $59.23
  • MDAIW $0.90
  • Technical
  • Relative Strength Index (RSI)
  • HROW 58.69
  • MDAIW N/A
  • Support Level
  • HROW $25.68
  • MDAIW N/A
  • Resistance Level
  • HROW $28.79
  • MDAIW N/A
  • Average True Range (ATR)
  • HROW 1.38
  • MDAIW 0.00
  • MACD
  • HROW 0.14
  • MDAIW 0.00
  • Stochastic Oscillator
  • HROW 80.11
  • MDAIW 0.00

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: